Looking for a naltrexone? Not a problem! Discreet Package Low Prices 24/7/365 Customer Support 100% Satisfaction Guaranteed. >>> ENTER SITE <<<
Tags:
The FDA announced the approval of the new weight-loss drug on Sept. 11, 2014. The drug name is Contrave.
Using two separate drugs to shed weight can be very effective you will find combinations as you're watching FDA now awaiting approval. When dealing with weight loss and the individuals who go through it you need to err to the side of caution and allow the FDA do its job and demand some research be done so that the public recognizes the side effects and perils associated with the medications before we take them. Keep in mind that drug companies will be in business to generate income and that they would say everything to keep people on his or her medications.
Researchers discovered that participants taking this drug for a year, dropped a few pounds within 4 weeks and have kept the load off during the entire 56 weeks of the study. Contrave is really a combination from the drugs naltrexone and bupropion, which usually reflect a brand new trend of weight-loss drugs which can be made up of multiple active ingredient, that might make them more effective and safer.
Combo-pilling is the newest fad or even better the newest to come under scrutiny and for that reason it is just more publicly known in recent months, comb-pilling to lose weight has been around since the eighties. The biggest reason that using a combination of pills has become popular will be the fact that since right now there are no long term prescription weight loss supplements that have been licensed by the FDA apart from orlistat. The truly disturbing part is doctors are prescribing these combinations of medications although some people might of the combinations are actually rejected or have yet to be approved by the FDA.
Seizures can be a side effect with Contrave and shouldn't be taken in individuals with seizure disorders. The drug may also raise hypertension and heart rate, and mustn't be used in those with a history of cardiac event or stroke in the previous six months. Blood pressure and pulse should also be measured before commencing the drug and throughout therapy with the drug.
The FDA also warned that Contrave can raise blood pressure level and heartbeat and must stop used in patients with uncontrolled high blood pressure levels, and also by anyone with heart-related and cerebrovascular (circulatory dysfunction impacting the mind) disease. Patients which has a history of heart attack or stroke in the last six months, life-threatening arrhythmias, or congestive heart failure were excluded through the clinical trials. Those taking Contrave needs to have their heart-rate and pulse monitored regularly. In addition, since compound includes bupropion, Contrave comes with a boxed warning to alert medical researchers and patients towards the increased probability of suicidal thoughts and behaviors connected with antidepressant drugs. The warning also notes that serious neuropsychiatric events happen to be reported in patients taking bupropion for stop smoking.
"There were no indications of depression or suicidal thoughts in trial participants," said Fujioka.
